Medical Letter on the CDC and FDA

Biotechnology - MICROFLUIDICS INTRODUCES WIDE RANGE OF MICROFLUIDIZER® PROCESSORS FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES Aseptic, Enhanced, and Basic Models Meet Industry-Specific Needs

Breast Cancer - First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama

Breast Cancer Screening - The Honorable Edward M. Kennedy, Scientists Mina J. Bissell and Susan Band Horwitz, and Philanthropist Jon M. Huntsman to Receive American Cancer Society Highest Honor for Outstanding Contributions to Cancer Fight

Campaign for Tobacco-Free Kids - Guatemala's Congress Takes Action to Save Lives By Approving Strong Smoke-free Legislation

Candidiasis - TYRX, Inc. Announces 1,000th Implant of AIGISRx(TM) Anti-Bacterial Envelope

CVS Caremark - CVS Caremark Applauds FTC's Leadership on Follow-on Biologics

Depression - Valdoxan(R), the First Melatonergic Antidepressant, Receives EU CHMP Positive Opinion for Major Depressive Disorder

Diabetes - Noninvasive Medical Technologies Helps Make Young Tennessee Woman's Wishes Come True

Drug Development - Drugs.com Unveils the Next Generation Medication Safety Tool to Help Consumers Avoid Dangerous Drug Interactions

Drug Development - Labopharm's NDA for Novel Trazodone Formulation accepted for review by FDA

Drug Resistance - Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections

ECO2 Plastics, Inc. - ECO2 Plastics, Inc. Receives Favorable FDA Opinion Letter Approving the Use of Its Recycled Plastic Flake in Food Packaging Applications

ETS Tan - Look Good, Feel Great This Holiday Season: Rejuvasun With Omnilux May Reduce Fine Lines, Wrinkles by up to 74 Percent

ExxonMobil Chemical - ExxonMobil Chemical's Vistamaxx Specialty Elastomers and Resins Achieve FDA and EU-Directive Compliance

GlaxoSmithKline - FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

Hepatocellular Cancer - Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma

HighPoint Solutions Llc - HighPoint Solutions Launches New Quality & Compliance Practice

HIV/AIDS Co-Infection - Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections

Huntington Disease - The First Treatment Specifically Approved for Huntington's Disease Patients is Now Available in the United States

JAMA and Archives Journals - Mammograms may detect some cancers that would have otherwise regressed

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. - FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain

Joshua Partners LLC - Joshua Partners LLC Completes Acquisition of Medicia Corp.

Lymphoma - Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug

Marketing and Licensing Agreements - MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States

Metabolism - Xceleron to Provide Otsuka Pharmaceutical Development & Commercialization, Inc. with META-ID Services to Obtain Critical Metabolism Information at Phase I

Michigan State University - MSU researcher studies ties between cholesterol drugs, muscle problems

Norwegian Institute of Public Health - Previous abortions and exercise: Do they affect pregnancy?

Pancreatic Cancer - New Cancer Treatment Shrinks Pancreatic Tumor

Patents - Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg

PLC Systems Inc. - PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in the U.S.

Regulatory Actions - Caraco Pharmaceutical Laboratories, Ltd. Responds to FDA Warning Letter

Schizophrenia - Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention

Servier - Valdoxan, the First Melatonergic Antidepressant, Receives EU CHMP Positive Opinion for Major Depressive Disorder

Stem Cell Research - t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application

Thrombosis - Thirty-Seven Patients Treated With Ultrasound Accelerated Catheter Direct Pharmacological Thrombolysis New Patient Data Presented At the 35th Annual VEITHsymposium in New York

University of Rochester Medical Center - Transfusions increase clot risk in hospitalized cancer patients